Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue from Contract with Customer [Abstract]

Net product revenues by product for the three and nine months ended September 30, 2022 and 2021 were as follows (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
YUTIQ (A)	$	7,273	$	3,928	$	19,305	$	11,124
DEXYCU (B)		2,447		4,659		10,743		13,003
Total product sales, net	$	9,720	$	8,587	$	30,048	$	24,127

(a)

Included approximately $4 and $71 of revenue from YUTIQ product sales to Ocumension Therapeutics under a supply agreement for the three and nine months ended September 30, 2022, respectively, and approximately $0 and $19 of revenue from YUTIQ product sales to Ocumension Therapeutics under a supply agreement for the three and nine months ended September 30, 2021, respectively.

(b)

Included approximately $16 of revenue from DEXYCU product sales to Ocumension Therapeutics under a supply agreement for the three and nine months ended September 30, 2022, respectively, and approximately $32 of revenue from DEXYCU product sales to Ocumension Therapeutics under a supply agreement for the three and nine months ended September 30, 2021, respectively.

Product Revenue Allowances and Reserves

The following table summarizes activity in each of the product revenue allowance and reserve categories for the nine months ended September 30, 2022 and 2021 (in thousands):


	Chargebacks, Discounts			Government and Other
	and Fees			Rebates			Returns			Total
Beginning balance at January 1, 2022	$	1,153		$	1,821		$	379		$	3,353
Provision related to sales in the current year		8,913			5,424			464			14,801
Adjustments related to prior period sales		—			—			—			—
Deductions applied and payments made		(8,092	)		(5,293	)		(259	)		(13,644	)
Ending balance at September 30, 2022	$	1,974		$	1,952		$	584		$	4,510

	Chargebacks, Discounts			Government and Other
	and Fees			Rebates			Returns			Total
Beginning balance at January 1, 2021	$	574		$	535		$	603		$	1,712
Provision related to sales in the current year		4,990			3,686			706			9,382
Adjustments related to prior period sales		(50	)		(22	)		(200	)		(272	)
Deductions applied and payments made		(4,631	)		(2,404	)		(704	)		(7,739	)
Ending balance at September 30, 2021	$	883		$	1,795		$	405		$	3,083